BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 26590805)

  • 21. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
    Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
    BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
    Mu Y; Zou H; Chen B; Fan Y; Luo S
    Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway.
    Ren Y; Tao J; Jiang Z; Guo D; Tang J
    Life Sci; 2018 Sep; 209():267-273. PubMed ID: 30107167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of secretagogin promotes cell apoptosis and inhibits migration and invasion of human SW480 human colorectal cancer cells.
    Yang XY; Liu QR; Wu LM; Zheng XL; Ma C; Na RS
    Biomed Pharmacother; 2018 May; 101():342-347. PubMed ID: 29499408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer.
    Rashed HE; Hussein S; Mosaad H; Abdelwahab MM; Abdelhamid MI; Mohamed SY; Mohamed AM; Fayed A
    Cancer Biomark; 2017 Jul; 20(1):107-122. PubMed ID: 28759954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways.
    Zhou ZP; Wang LP; Hong ZS; Qiu CZ; Wang MZ; Chen ZX; Tang LF; Yu WS; Wang CX
    Int J Oncol; 2018 Sep; 53(3):1183-1192. PubMed ID: 30015866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tescalcin expression contributes to invasive and metastatic activity in colorectal cancer.
    Kang J; Kang YH; Oh BM; Uhm TG; Park SY; Kim TW; Han SR; Lee SJ; Lee Y; Lee HG
    Tumour Biol; 2016 Oct; 37(10):13843-13853. PubMed ID: 27485112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways.
    Wei ZJ; Tao ML; Zhang W; Han GD; Zhu ZC; Miao ZG; Li JY; Qiao ZB
    Int J Clin Exp Pathol; 2015; 8(5):4481-91. PubMed ID: 26191138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
    Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
    Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism.
    Wang B; Shen ZL; Jiang KW; Zhao G; Wang CY; Yan YC; Yang Y; Zhang JZ; Shen C; Gao ZD; Ye YJ; Wang S
    BMC Cancer; 2015 May; 15():437. PubMed ID: 26016795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and humoral response of A-kinase anchor protein 4 in cervical cancer.
    Agarwal S; Saini S; Parashar D; Verma A; Jagadish N; Batra A; Suri S; Bhatnagar A; Gupta A; Ansari AS; Lohiya NK; Suri A
    Int J Gynecol Cancer; 2013 May; 23(4):650-8. PubMed ID: 23478221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of miR‑490‑3p in colorectal cancer predicts poor prognosis and promotes cell proliferation and invasion by targeting RAB14.
    Wang B; Yin M; Cheng C; Jiang H; Jiang K; Shen Z; Ye Y; Wang S
    Int J Oncol; 2018 Sep; 53(3):1247-1256. PubMed ID: 29916545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer.
    Kang JH; Jang JE; Mishra SK; Lee HJ; Nho CW; Shin D; Jin M; Kim MK; Choi C; Oh SH
    J Ethnopharmacol; 2015 Sep; 173():303-12. PubMed ID: 26210065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BMP3 suppresses colon tumorigenesis via ActRIIB/SMAD2-dependent and TAK1/JNK signaling pathways.
    Wen J; Liu X; Qi Y; Niu F; Niu Z; Geng W; Zou Z; Huang R; Wang J; Zou H
    J Exp Clin Cancer Res; 2019 Oct; 38(1):428. PubMed ID: 31665064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
    Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
    Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Cancer Effect of α-Solanine by Down-Regulating S100P Expression in Colorectal Cancer Cells.
    Ni X; Chen J; Lu F; Yuan Z; Xu X; Hu Z; Jiang L
    Recent Pat Anticancer Drug Discov; 2018; 13(2):240-247. PubMed ID: 29600769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer.
    Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
    Oncol Rep; 2018 Oct; 40(4):2215-2223. PubMed ID: 30015962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of allograft inflammatory factor-1 in regulating the proliferation, migration and apoptosis of colorectal cancer cells].
    Ai XL; Yao F; Wang XJ; Duan DB; Li K; Hu ZY; Yin G; Wang M; Wu BY
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 May; 38(5):511-519. PubMed ID: 29891445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition.
    Al-Qasem A; Al-Howail HA; Al-Swailem M; Al-Mazrou A; Al-Otaibi B; Al-Jammaz I; Al-Khalaf HH; Aboussekhra A
    Mol Carcinog; 2016 Mar; 55(3):233-44. PubMed ID: 25641341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.